ryan braun wide getty

In focusing on Braun, Major League Baseball is abandoning the principles of its drug testing/enforcement program

36 Comments

Been doing some more thinking about the story this morning about how Major League Baseball is laser-focused on Ryan Braun in the Biogenesis investigation, to the point where it is considering giving players immunity in an effort to nab him and some of the bigger fish.

As a basic premise, I don’t have a real problem with that. This is how police work is usually done: get the small fish to flip on the big fish and so forth. I think this differs from the organized crime analogy in that here the “big fish” is only one player whose violation is no different in kind or magnitude than that of any other person cheating — and, as such, going after Braun like this is likely to cause MLB to overlook multiple more cheaters who collectively represent a greater ill to baseball than one more famous cheater — but that’s their prerogative. If they get the goods on Braun and punish him, fine, he’s punished.

All of that said, in pursuing things in such a way it’s inescapable that Major League Baseball is abandoning some of the core principles of the drug program as currently constructed.

For one thing: zero tolerance. The most adamant anti-PED folks on the planet, including WADA and USADA have spent decades telling us that zero tolerance is critical to any drug testing regime and that only through zero tolerance can you have a level competitive landscape. In singling out Braun, however, and standing willing to grant immunity to some players in order to get him, Major League Baseball is abandoning that principle. It is saying that some cheaters are more important than others. Which is the same as saying that some cheating will, in effect, be tolerated and will go unpunished.

And maybe Major League Baseball is fine with that. If so, they should say so. And if so they should cease selectively applying the standards of zero tolerance. I mean, if MLB is satisfied that it can weigh the words and determine the truthfulness of one player’s word over another’s and that it can mete out differential enforcement like this and not harm the very essence of the Joint Drug Agreement, surely it can listen to defenses of inadvertent contamination and accidental ingestion of various stimulants and PEDs, can it not? Now Bud Selig says that it can’t do that for risk of imperiling zero tolerance principles. But if the Biogenesis investigation throws such principles over the side, what is left to protect?

Also being abandoned right now: the anonymity of the testing and enforcement process.  Major League Baseball’s fixation on Braun is of such a high pitch, it appears, that it was deemed unique and newsworthy by someone privy to the process and thus was leaked to Bob Nightengale of USA Today. Since when is that acceptable? The last time news of a drug investigation/enforcement proceeding was made public it led to MLB being publicly embarrassed when that outfielder from Milwaukee beat the rap. How did that turn out for you, Mr. Selig? And how has it turned out for that outfielder, whose name will always be mud to some folks regardless of what the future holds?

If Ryan Braun cheated — and if Major League Baseball can prove it — yes, he should absolutely be punished. And at this point, if what Nightengale is reporting is true, I’d lay better odds on Braun getting popped than him getting off.  But in getting that head on a platter it’s inescapable that Major League Baseball is transforming its drug testing and enforcement regime from a clinically-based program into a police operation.  And in doing so, it appears willing to abandon zero tolerance, anonymity, uniform enforcement and everything the league tells us is so good about the Joint Drug Agreement in the first place.

Hope it’s worth it, guys.

Reds place Devin Mesoraco on the disabled list with a torn labrum

Cincinnati Reds' Devin Mesoraco watches from the dugout during the ninth inning of a baseball game against the Pittsburgh Pirates in Pittsburgh, Saturday, April 30, 2016. The Pirates won 5-1. (AP Photo/Gene J. Puskar)
AP Photo/Gene J. Puskar
Leave a comment

The Reds have placed catcher Devin Mesoraco on the 15-day disabled list with a torn labrum in his left shoulder, C. Trent Rosecrans of the Cincinnati Enquirer reportsRosecrans adds that Mesoraco and the Reds will discuss whether or not the catcher will undergo surgery.

To fill Mesoraco’s roster spot, the club called up catcher Ramon Cabrera from Triple-A Louisville. Tucker Barnhart is expected to start the lion’s share of games in Mesoraco’s absence.

Mesoraco was scuffling prior to the injury, as he was batting a mere .140/.218/.160 with only one extra-base hit and one RBI in 55 plate appearances.

Dodgers’ Josh Ravin suspended 80 games for using a banned substance

Los Angeles Dodgers' Josh Ravin, right, reacts as New York Mets' Lucas Duda (21) runs the bases after hitting a home run during the seventh inning of a baseball game Saturday, July 25, 2015, in New York. (AP Photo/Frank Franklin II)
AP Photo/Frank Franklin II
1 Comment

Update #2 (6:53 PM EDT): Ravin released a statement through the players’ union. Mike DiGiovanna of the Los Angeles Times provides it:

*

Update (6:35 PM EDT): MLB made the announcement.

*

Jeff Passan of Yahoo Sports is reporting that Dodgers pitcher Josh Ravin will be suspended 80 games after testing positive for a banned substance. When it is made official by Major League Baseball, Ravin will be the sixth major league player to earn a suspension after testing positive, joining Dee Gordon, Chris Colabello, Abraham Almonte, Daniel Stumpf, and Jenrry Mejia.

Ravin, 28, hasn’t pitched this year as he broke his arm in a car accident during spring training, but was expected to return before the end of May. He debuted in the majors last season, making nine relief appearances for the Dodgers. He yielded seven runs on 13 hits and four walks with 12 strikeouts in 9 1/3 innings. Ravin made 22 appearances for Triple-A Oklahoma City as well.

Ravin will be eligible to return in early August.

The Braves made a flurry of roster moves ahead of Monday’s game

Atlanta Braves starter Mike Foltynewicz throws against the Chicago Cubs during the first inning of a baseball game Thursday, Aug. 20, 2015, in Chicago. (AP Photo/Nam Y. Huh)
AP Photo/Nam Y. Huh
Leave a comment

On the heels of Sunday’s transaction snafu, the Braves made a flurry of roster moves — seven, to be exact — on Monday, the club announced. Pitcher Mike Foltynewicz was recalled from Triple-A Gwinnett. The contracts of utilityman Chase d’Arnaud, outfielder Matt Tuiasosopo, and infielder Reid Brignac were selected from Gwinnett. Pitcher John Gant and utilityman Jace Peterson were optioned to Gwinnett. Outfielder Drew Stubbs was designated for assignment.

Whew.

Foltynewicz is starting Monday night’s game against the Mets, opposite Bartolo Colon. In four starts with Gwinnett, Foltynewicz put up a 2.05 ERA with a 20/14 K/BB ratio in 22 innings. Control has always been an issue for the right-hander, though he was able to limit the walks to 29 over 86 2/3 major league innings last year.

The Braves enter play Monday at 6-18, the worst record in baseball. The club is reportedly embracing the tank and is now trying to buy draft picks by taking on bad contracts.

J.J. Hardy to miss four to eight weeks with a hairline fracture in his right foot

Baltimore Orioles' J.J. Hardy watches his double during the second inning of a baseball game against the Boston Red Sox, Wednesday, June 10, 2015, in Baltimore. Delmon Young scored on the play. (AP Photo/Patrick Semansky)
AP Photo/Patrick Semansky
1 Comment

Orioles shortstop J.J. Hardy is expected to miss four to eight weeks due to a hairline fracture in his right foot, MASN’s Roch Kubatko reports. Hardy suffered the injury fouling a ball off of his foot in the fourth inning of Sunday’s game against the White Sox.

The Orioles have some options when it comes to replacing Hardy. Third baseman Manny Machado could move to shortstop, his natural position, and Ryan Flaherty would cover third base. Paul Janish is another option, but he’ll be leaving Triple-A Norfolk on Wednesday for the birth of his child. As Kubatko notes, both Pedro Alvarez and Chris Davis could also play third base in a pinch.

Hardy, 33, is batting .244/.291/.410 with a pair of home runs and eight RBI over 86 plate appearances to begin the season. That’s markedly better than the meager .219/.253/.311 line he put up last year.